{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T05:38:25Z","timestamp":1769924305304,"version":"3.49.0"},"reference-count":160,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2022,7,17]],"date-time":"2022-07-17T00:00:00Z","timestamp":1658016000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012190","name":"Ministry of Science and Higher Education of the Russian Federation","doi-asserted-by":"publisher","award":["075-15-2022-322"],"award-info":[{"award-number":["075-15-2022-322"]}],"id":[{"id":"10.13039\/501100012190","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Plants"],"abstract":"<jats:p>In late December 2019, the first cases of COVID-19 emerged as an outbreak in Wuhan, China that later spread vastly around the world, evolving into a pandemic and one of the worst global health crises in modern history. The causative agent was identified as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Although several vaccines were authorized for emergency use, constantly emerging new viral mutants and limited treatment options for COVID-19 drastically highlighted the need for developing an efficient treatment for this disease. One of the most important viral components to target for this purpose is the main protease of the coronavirus (Mpro). This enzyme is an excellent target for a potential drug, as it is essential for viral replication and has no closely related homologues in humans, making its inhibitors unlikely to be toxic. Our review describes a variety of approaches that could be applied in search of potential inhibitors among plant-derived compounds, including virtual in silico screening (a data-driven approach), which could be structure-based or fragment-guided, the classical approach of high-throughput screening, and antiviral activity cell-based assays. We will focus on several classes of compounds reported to be potential inhibitors of Mpro, including phenols and polyphenols, alkaloids, and terpenoids.<\/jats:p>","DOI":"10.3390\/plants11141862","type":"journal-article","created":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T01:53:22Z","timestamp":1658109202000},"page":"1862","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["The Main Protease of SARS-CoV-2 as a Target for Phytochemicals against Coronavirus"],"prefix":"10.3390","volume":"11","author":[{"given":"Shaza S.","family":"Issa","sequence":"first","affiliation":[{"name":"Department of Genetics and Biotechnology, St. Petersburg State University, 199034 St. Petersburg, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6718-4818","authenticated-orcid":false,"given":"Sofia V.","family":"Sokornova","sequence":"additional","affiliation":[{"name":"Department of Genetics and Biotechnology, St. Petersburg State University, 199034 St. Petersburg, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roman R.","family":"Zhidkin","sequence":"additional","affiliation":[{"name":"Department of Genetics and Biotechnology, St. Petersburg State University, 199034 St. Petersburg, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8569-6665","authenticated-orcid":false,"given":"Tatiana V.","family":"Matveeva","sequence":"additional","affiliation":[{"name":"Department of Genetics and Biotechnology, St. Petersburg State University, 199034 St. Petersburg, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,7,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jmii.2020.02.001","article-title":"Emerging threats from zoonotic coronaviruses-from SARS and MERS to 2019-nCoV","volume":"53","author":"Lee","year":"2020","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1056\/NEJMoa2001316","article-title":"Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia","volume":"382","author":"Li","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"Wu","year":"2020","journal-title":"Nature"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A Novel Coronavirus from Patients with Pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"101578","DOI":"10.1016\/j.tmaid.2020.101578","article-title":"Going global\u2014Travel and the 2019 novel coronavirus","volume":"33","author":"MacGregor","year":"2020","journal-title":"Travel Med. Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"118919","DOI":"10.1016\/j.lfs.2020.118919","article-title":"DNA vaccines against COVID-19: Perspectives and challenges","volume":"267","author":"Silveira","year":"2020","journal-title":"Life Sci."},{"key":"ref_7","unstructured":"WHO (2022, May 05). COVID-19 Dashboard. Available online: https:\/\/covid19.who.int\/."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2040330","DOI":"10.1080\/21645515.2022.2040330","article-title":"mRNA vaccine-a desirable therapeutic strategy for surmounting COVID-19 pandemic","volume":"18","author":"Chen","year":"2022","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","article-title":"Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors","volume":"582","author":"Jin","year":"2020","journal-title":"Nature"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1021\/acs.jcim.1c01087","article-title":"Screening for Inhibitors of Main Protease in SARS-CoV-2: In Silico and In Vitro Approach Avoiding Peptidyl Secondary Amides","volume":"62","author":"Yamamoto","year":"2022","journal-title":"J. Chem. Inf. Model."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2027197","DOI":"10.1080\/21645515.2022.2027197","article-title":"Strategies to tackle SARS-CoV-2 Mu, a newly classified variant of interest likely to resist currently available COVID-19 vaccines","volume":"18","author":"Hossain","year":"2022","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/s41564-021-00932-w","article-title":"SARS-CoV-2 Variants of Interest and Concern naming scheme conducive for global discourse","volume":"6","author":"Konings","year":"2021","journal-title":"Nat. Microbiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1080\/21645515.2021.1923350","article-title":"Emerging SARS-CoV-2 variants: Impact on vaccine efficacy and neutralizing antibodies","volume":"17","author":"Sharun","year":"2021","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Van Egeren, D., Novokhodko, A., Stoddard, M., Tran, U., Zetter, B., Rogers, M., and Chakravarty, A. (2021). Risk of rapid evolutionary escape from biomedical interventions targeting SARS-CoV-2 spike protein. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0250780"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13578-021-00643-z","article-title":"SARS-CoV-2: From its discovery to genome structure, transcription, and replication","volume":"11","author":"Brant","year":"2021","journal-title":"Cell Biosci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/jmv.25681","article-title":"Emerging coronaviruses: Genome structure, replication, and pathogenesis","volume":"92","author":"Chen","year":"2020","journal-title":"J. Med. Virol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1126\/science.abb4489","article-title":"Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease","volume":"368","author":"Dai","year":"2020","journal-title":"Science"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1042\/BST0391371","article-title":"Recent development of 3C and 3CL protease inhibitors for anti-coronavirus and anti-picornavirus drug discovery","volume":"39","author":"Ramajayam","year":"2011","journal-title":"Biochem. Soc. Trans."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/pro.4075","article-title":"Characterization of the SARS-CoV-2 E Protein: Sequence, Structure, Viroporin, and Inhibitors","volume":"30","author":"Cao","year":"2021","journal-title":"Protein Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.cell.2020.04.011","article-title":"The Architecture of SARS-CoV-2 Transcriptome","volume":"181","author":"Kim","year":"2020","journal-title":"Cell"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"490","DOI":"10.5114\/aoms.2020.94655","article-title":"Statins and the COVID-19 main protease: In silico evidence on direct interaction","volume":"16","author":"Reiner","year":"2020","journal-title":"Arch. Med. Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1080\/07391102.2020.1834457","article-title":"Structural basis for the inhibition of SARS-CoV2 main protease by Indian medicinal plant-derived antiviral compounds","volume":"40","author":"Saravanan","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Yang, H., Xie, W., Xue, X., Yang, K., Ma, J., Liang, W., and Rao, Z. (2005). Design of wide-spectrum inhibitors targeting coronavirus main proteases. PLoS Biol., 3.","DOI":"10.1371\/journal.pbio.0030428"},{"key":"ref_25","first-page":"1","article-title":"A higher flexibility at the SARS-CoV-2 main protease active site compared to SARS-CoV and its potentialities for new inhibitor virtual screening targeting multi-conformers","volume":"10","author":"Rocha","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1111\/1462-2920.15487","article-title":"SARS-CoV-2 biology and variants: Anticipation of viral evolution and what needs to be done","volume":"23","author":"Luo","year":"2021","journal-title":"Environ. Microbiol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"M\u00f3ty\u00e1n, J.A., Mahdi, M., Hoffka, G., and T\u0151zs\u00e9r, J. (2022). Potential Resistance of SARS-CoV-2 Main Protease (Mpro) against Protease Inhibitors: Lessons Learned from HIV-1 Protease. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23073507"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1007\/s11030-021-10298-0","article-title":"Structure-based virtual screening, in silico docking, ADME properties prediction and molecular dynamics studies for the identification of potential inhibitors against SARS-CoV-2 M(pro)","volume":"26","author":"Mohan","year":"2021","journal-title":"Mol. Divers."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/978-1-59745-177-2_19","article-title":"Molecular docking","volume":"443","author":"Morris","year":"2008","journal-title":"Methods Mol. Biol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"730","DOI":"10.4274\/tjps.galenos.2021.25564","article-title":"In silico Repurposing of Drugs for pan-HDAC and pan-SIRT Inhibitors: Consensus Structure-based Virtual Screening and Pharmacophore Modeling Investigations","volume":"18","author":"Sari","year":"2021","journal-title":"Turk. J. Pharm. Sci."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Pinzi, L., and Rastelli, G. (2019). Molecular Docking: Shifting Paradigms in Drug Discovery. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20184331"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.3389\/fphar.2019.01675","article-title":"Applying Machine Learning to Ultrafast Shape Recognition in Ligand-Based Virtual Screening","volume":"10","author":"Bonanno","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1517\/17460441.2016.1117070","article-title":"An overview of molecular fingerprint similarity search in virtual screening","volume":"11","author":"Muegge","year":"2015","journal-title":"Expert Opin. Drug Discov."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Pinto, G.P., Hendrikse, N.M., Stourac, J., Damborsky, J., and Bednar, D. (2021). Virtual screening of potential anticancer drugs based on microbial products. Seminars in Cancer Biology, Academic Press.","DOI":"10.20944\/preprints202102.0529.v1"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"709","DOI":"10.3389\/fchem.2019.00709","article-title":"Fast Screening of Inhibitor Binding\/Unbinding Using Novel Software Tool CaverDock","volume":"7","author":"Pinto","year":"2019","journal-title":"Front. Chem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1002\/ptr.6700","article-title":"Natural products and their derivatives against coronavirus: A review of the non-clinical and pre-clinical data","volume":"34","author":"Islam","year":"2020","journal-title":"Phytother. Res."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Olubiyi, O.O., Olagunju, M., Keutmann, M., Loschwitz, J., and Strodel, B. (2020). High Throughput Virtual Screening to Discover Inhibitors of the Main Protease of the Coronavirus SARS-CoV-2. Molecules, 25.","DOI":"10.20944\/preprints202004.0161.v2"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.joim.2020.02.005","article-title":"In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus","volume":"18","author":"Zhang","year":"2020","journal-title":"J. Integr. Med."},{"key":"ref_39","first-page":"3099","article-title":"Discovery of potential multi-target-directed ligands by targeting host-specific SARS-CoV-2 structurally conserved main protease","volume":"39","author":"Joshi","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"6307457","DOI":"10.1155\/2020\/6307457","article-title":"Potential of Plant Bioactive Compounds as SARS-CoV-2 Main Protease (Mpro) and Spike (S) Glycoprotein Inhibitors: A Molecular Docking Study","volume":"2020","author":"Tallei","year":"2020","journal-title":"Scientifica"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jpha.2020.03.009","article-title":"Structural basis of SARS-CoV-2 3CL(pro) and anti-COVID-19 drug discovery from medicinal plants","volume":"10","author":"Alqahtani","year":"2020","journal-title":"J. Pharm. Anal."},{"key":"ref_42","first-page":"2020030226","article-title":"Potential Inhibitor of COVID-19 Main Protease (Mpro) from Several Medicinal Plant Compounds by Molecular Docking Study","volume":"2020","author":"Khaerunnisa","year":"2020","journal-title":"Preprints"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"da Silva JK, R., Figueiredo PL, B., Byler, K.G., and Setzer, W.N. (2020). Essential Oils as Antiviral Agents, Potential of Essential Oils to Treat SARS-CoV-2 Infection: An In-Silico Investigation. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21103426"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Mohamed, M.E., Tawfeek, N., Elbaramawi, S.S., and Fikry, E. (2022). Agathis robusta Bark Essential Oil Effectiveness against COVID-19: Chemical Composition, In Silico and In Vitro Approaches. Plants, 11.","DOI":"10.3390\/plants11050663"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"6312","DOI":"10.1002\/slct.202000822","article-title":"Evaluation of the Inhibitory Activities of COVID-19 of Melaleuca cajuputi Oil Using Docking Simulation","volume":"5","author":"My","year":"2020","journal-title":"ChemistrySelect"},{"key":"ref_46","unstructured":"Wexler, P. (2014). High Throughput Screening. Encyclopedia of Toxicology, Academic Press. [3rd ed.]."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Ismail, F.M., Nahar, L., and Sarker, S.D. (2018). High-Throughput Screening of Phytochemicals: Application of Computational Methods. Comput. Phytochem., 165\u2013192.","DOI":"10.1016\/B978-0-12-812364-5.00006-7"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Lundblad, R.L. (2016). Drug Design. Encyclopedia of Cell Biology, Elsevier.","DOI":"10.1016\/B978-0-12-394447-4.10015-X"},{"key":"ref_49","first-page":"112","article-title":"Review on: High-throughput screening is an approach to drug discovery","volume":"4","author":"Hajare","year":"2013","journal-title":"Am. J. Pharm. Tech. Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ijid.2020.12.033","article-title":"A high-throughput drug screening strategy against coronaviruses","volume":"103","author":"Liu","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1016\/j.drudis.2021.05.012","article-title":"High-throughput screening assays for SARS-CoV-2 drug development: Current status and future directions","volume":"26","author":"Xu","year":"2021","journal-title":"Drug Discov. Today"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"001583","DOI":"10.1099\/jgv.0.001583","article-title":"SARS-CoV-2 replicon for high-throughput antiviral screening","volume":"102","author":"Zhang","year":"2021","journal-title":"J. Gen. Virol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s13238-021-00836-9","article-title":"High-throughput screening identifies established drugs as SARS-CoV-2 PLpro inhibitors","volume":"12","author":"Zhao","year":"2021","journal-title":"Protein Cell"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1021\/acsptsci.0c00108","article-title":"Identification of SARS-CoV-2 3CL Protease Inhibitors by a Quantitative High-Throughput Screening","volume":"3","author":"Zhu","year":"2020","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e01265-20","DOI":"10.1128\/JVI.01265-20","article-title":"Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL(pro) Reporter Assay","volume":"94","author":"Froggatt","year":"2020","journal-title":"J. Virol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"102021","DOI":"10.1016\/j.isci.2020.102021","article-title":"A multi-pronged approach targeting SARS-CoV-2 proteins using ultra-large virtual screening","volume":"24","author":"Gorgulla","year":"2021","journal-title":"iScience"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/nrd2876","article-title":"Multi-parameter phenotypic profiling: Using cellular effects to characterize small-molecule compounds","volume":"8","author":"Feng","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4014\/jmb.1508.08007","article-title":"Cell-Based Assay Design for High-Content Screening of Drug Candidates","volume":"26","author":"Nierode","year":"2016","journal-title":"J. Microbiol. Biotechnol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"494","DOI":"10.2174\/138620708785204135","article-title":"Cell-based screening","volume":"11","author":"Zaman","year":"2008","journal-title":"Comb. Chem. High Throughput Screen"},{"key":"ref_60","first-page":"557","article-title":"In vitro methods for testing antiviral drugs","volume":"36","author":"Ruml","year":"2017","journal-title":"Biotechnol. Adv."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1517\/17460441.3.6.671","article-title":"Cell-based assays to identify inhibitors of viral disease","volume":"3","author":"Green","year":"2008","journal-title":"Expert Opin. Drug Discov."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0166-3542(83)90001-3","article-title":"A colorimetric assay for the measurement of the sensitivity of herpes simplex viruses to antiviral agents","volume":"3","author":"McLaren","year":"1983","journal-title":"Antivir. Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/1087057106296688","article-title":"Development and Validation of a High-Throughput Screen for Inhibitors of SARS-CoV and Its Application in Screening of a 100,000-Compound Library","volume":"12","author":"Severson","year":"2007","journal-title":"SLAS Discov. Adv. Sci. Drug Discov."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.antiviral.2005.06.006","article-title":"Cell-based and biochemical screening approaches for the discovery of novel HIV-1 inhibitors","volume":"67","author":"Westby","year":"2005","journal-title":"Antivir. Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1128\/AAC.45.9.2616-2622.2001","article-title":"Cell-Based Fluorescence Assay for Human Immunodeficiency Virus Type 1 Protease Activity","volume":"45","author":"Lindsten","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jviromet.2006.06.003","article-title":"Screening for HIV protease inhibitors by protection against activity-mediated cytotoxicity in Escherichia coli","volume":"137","author":"Cheng","year":"2006","journal-title":"J. Virol. Methods"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1042\/BCJ20210200","article-title":"Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp12\/7\/8 RNA-dependent RNA polymerase","volume":"478","author":"Bertolin","year":"2021","journal-title":"Biochem. J."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"e2021579118","DOI":"10.1073\/pnas.2021579118","article-title":"Identification of existing pharmaceuticals and herbal medicines as inhibitors of SARS-CoV-2 infection","volume":"118","author":"Jan","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"4454","DOI":"10.1002\/jmv.26917","article-title":"In vitro activity of itraconazole against SARS-CoV-2","volume":"93","author":"Bojkova","year":"2021","journal-title":"J. Med. Virol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"105078","DOI":"10.1016\/j.antiviral.2021.105078","article-title":"A cell-based assay to discover inhibitors of SARS-CoV-2 RNA dependent RNA polymerase","volume":"190","author":"Zhao","year":"2021","journal-title":"Antiviral Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1126\/science.abf1611","article-title":"SARS-CoV-2 M(pro) inhibitors with antiviral activity in a transgenic mouse model","volume":"371","author":"Qiao","year":"2021","journal-title":"Science"},{"key":"ref_72","first-page":"69","article-title":"The value of plants used in traditional medicine for drug discovery","volume":"109","author":"Fabricant","year":"2001","journal-title":"Environ. Health Perspect."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"583387","DOI":"10.3389\/fphar.2021.583387","article-title":"Plant Products as Inhibitors of Coronavirus 3CL Protease","volume":"12","author":"Mandal","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1126\/science.190.4217.880","article-title":"Shanidar IV, a Neanderthal Flower Burial in Northern Iraq","volume":"190","author":"Solecki","year":"1975","journal-title":"Science"},{"key":"ref_75","first-page":"8","article-title":"Natural product drug discovery in the next millennium","volume":"39","author":"Cragg","year":"2001","journal-title":"Pharm. Biol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/ptr.6575","article-title":"Antiviral activity of plants and their isolated bioactive compounds: An update","volume":"34","author":"Denaro","year":"2019","journal-title":"Phytother. Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"104933","DOI":"10.1016\/j.micpath.2021.104933","article-title":"Molecular scaffolds from mother nature as possible lead compounds in drug design and discovery against coronaviruses: A landscape analysis of published literature and molecular docking studies","volume":"157","author":"Khursheed","year":"2021","journal-title":"Microb. Pathog."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4103\/2225-4110.124335","article-title":"Antiviral Natural Products and Herbal Medicines","volume":"4","author":"Lin","year":"2014","journal-title":"J. Tradit. Complement. Med."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"012008","DOI":"10.1088\/1757-899X\/523\/1\/012008","article-title":"Djufri Activities inhibition methanol extract Laban Leaf (Vitex pinnata) on growth of bacteria S. mutans Atcc 31987","volume":"523","author":"Nuraskin","year":"2019","journal-title":"IOP Conf. Series Mater. Sci. Eng."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s13568-021-01305-6","article-title":"Decoding antibacterial and antibiofilm properties of cinnamon and cardamom essential oils: A combined molecular docking and experimental study","volume":"11","author":"Pourkhosravani","year":"2021","journal-title":"AMB Express"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"012011","DOI":"10.1088\/1757-899X\/523\/1\/012011","article-title":"Antibacterial cream formulation of ethanolic Pliek U extracts and ethanolic residue hexane Pliek U extracts against Staphylococcus aureus","volume":"523","author":"Rahmad","year":"2019","journal-title":"IOP Conf. Ser. Mater. Sci. Eng."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1099\/jmm.0.045054-0","article-title":"Candida species: Current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options","volume":"62","author":"Sardi","year":"2013","journal-title":"J. Med. Microbiol."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"El-Saber Batiha, G., Magdy Beshbishy, A., Wasef, L.G., Elewa, Y.H., Al-Sagan, A.A., El-Hack, A., Taha, M.E., Abd-Elhakim, Y.M., and Prasad Devkota, H. (2020). Chemical Constituents and Pharmacological Activities of Garlic (Allium sativum L.): A Review. Nutrients, 12.","DOI":"10.3390\/nu12030872"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s11418-021-01575-1","article-title":"Leveraging knowledge of Asian herbal medicine and its active compounds as COVID-19 treatment and prevention","volume":"76","author":"Liana","year":"2021","journal-title":"J. Nat. Med."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1080\/15321819.2020.1862867","article-title":"Herbal medicine, a reliable support in COVID therapy","volume":"41","author":"Grigore","year":"2020","journal-title":"J. Immunoass. Immunochem."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s11655-020-3476-x","article-title":"In Silico Screening of Potential Chinese Herbal Medicine Against COVID-19 by Targeting SARS-CoV-2 3CLpro and Angiotensin Converting Enzyme II Using Molecular Docking","volume":"26","author":"Gao","year":"2020","journal-title":"Chin. J. Integr. Med."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1080\/07391102.2020.1810778","article-title":"Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants\u2014Withania somnifera (Ashwagandha), Tinospora cordifolia (Giloy) and Ocimum sanctum (Tulsi)\u2014A molecular docking study","volume":"40","author":"Shree","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.nutos.2021.12.004","article-title":"Novel antiviral effects of chloroquine, hydroxychloroquine, and green tea catechins against SARS-CoV-2 main protease (Mpro) and 3C-like protease for COVID-19 treatment","volume":"42","author":"Shaik","year":"2022","journal-title":"Clin. Nutr. Open Sci."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"411","DOI":"10.6026\/97320630016411","article-title":"Molecular docking analysis of Withaferin A from Withania somnifera with the Glucose regulated protein 78 (GRP78) receptor and the SARS-CoV-2 main protease","volume":"16","author":"Sudeep","year":"2020","journal-title":"Bioinformation"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"104146","DOI":"10.1016\/j.jff.2020.104146","article-title":"Phytochemicals containing biologically active polyphenols as an effective agent against COVID-19-inducing coronavirus","volume":"73","author":"Chojnacka","year":"2020","journal-title":"J. Funct. Foods"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Nguyen TT, H., Jung, J.H., Kim, M.K., Lim, S., Choi, J.M., Chung, B., and Kim, D. (2021). The Inhibitory Effects of Plant Derivate Polyphenols on the Main Protease of SARS Coronavirus 2 and Their Structure-Activity Relationshi. Molecules, 26.","DOI":"10.3390\/molecules26071924"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Khwaza, V., Oyedeji, O.O., and Aderibigbe, B.A. (2018). Antiviral Activities of Oleanolic Acid and Its Analogues. Molecules, 23.","DOI":"10.3390\/molecules23092300"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"4110","DOI":"10.1080\/07391102.2020.1858164","article-title":"Depicting the inhibitory potential of polyphenols from Isatis indigotica root against the main protease of SARS-CoV-2 using computational approaches","volume":"40","author":"Ghosh","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2217\/fvl-2020-0099","article-title":"Possible SARS-coronavirus 2 inhibitor revealed by simulated molecular docking to viral main protease and host toll-like receptor","volume":"15","author":"Hu","year":"2020","journal-title":"Futur. Virol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.virol.2022.04.005","article-title":"Flavonols and dihydroflavonols inhibit the main protease activity of SARS-CoV-2 and the replication of human coronavirus 229E","volume":"571","author":"Zhu","year":"2022","journal-title":"Virology"},{"key":"ref_96","first-page":"1934578X211066723","article-title":"Naringenin as a possible candidate against SARS-CoV-2 infection and in the pathogenesis of COVID-19","volume":"16","author":"Agrawal","year":"2021","journal-title":"Nat. Prod. Commun."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Mishra, A., Rath, S.C., Baitharu, I., and Bag, B.P. (2020). Millet Derived Flavonoids as Potential SARS-CoV-2 Main Protease Inhibitors: A Computational Approach, Cambridge Open Engage.","DOI":"10.26434\/chemrxiv.12733622"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/s41401-020-0483-6","article-title":"Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients","volume":"41","author":"Su","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"153310","DOI":"10.1016\/j.phymed.2020.153310","article-title":"Caffeic acid derivatives (CAFDs) as inhibitors of SARS-CoV-2: CAFDs-based functional foods as a potential alternative approach to combat COVID-19","volume":"85","author":"Adem","year":"2021","journal-title":"Phytomedicine"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"131594","DOI":"10.1016\/j.foodchem.2021.131594","article-title":"Inhibition of the SARS-CoV-2 3CLpro main protease by plant polyphenols","volume":"373","author":"Bahun","year":"2022","journal-title":"Food Chem."},{"key":"ref_101","first-page":"61","article-title":"Dft calculations and in silico study of chlorogenic, ellagic and quisqualic acids as potential inhibitors of SARS-CoV-2 main protease mpro","volume":"12","author":"Shahab","year":"2022","journal-title":"Biointerface Res. Appl. Chem."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1007\/s00705-022-05483-x","article-title":"Anti-SARS-CoV-2 activity of various PET-bottled Japanese green teas and tea compounds in vitro","volume":"167","author":"Luvai","year":"2022","journal-title":"Arch. Virol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1002\/ptr.6998","article-title":"In silico and in vitro evaluation of kaempferol as a potential inhibitor of the SARS-CoV-2 main protease (3CLpro)","volume":"35","author":"Khan","year":"2021","journal-title":"Phytother. Res."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"19570","DOI":"10.1039\/D0RA03582C","article-title":"Molecular docking reveals the potential of Salvadora persica flavonoids to inhibit COVID-19 virus main protease","volume":"10","author":"Owis","year":"2020","journal-title":"RSC Adv."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Shahhamzehei, N., Abdelfatah, S., and Efferth, T. (2022). In Silico and In Vitro Identification of Pan-Coronaviral Main Protease Inhibitors from a Large Natural Product Library. Pharmaceuticals, 15.","DOI":"10.3390\/ph15030308"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"13205","DOI":"10.1021\/acs.jmedchem.0c00626","article-title":"Chinese therapeutic strategy for fighting COVID-19 and potential small-molecule inhibitors against severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2)","volume":"63","author":"Choudhry","year":"2020","journal-title":"J. Med. Chem."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/14756366.2019.1690480","article-title":"Inhibition of SARS-CoV 3CL protease by flavonoids","volume":"35","author":"Jo","year":"2020","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"22796","DOI":"10.1038\/s41598-021-02266-3","article-title":"An integrated method for optimized identification of effective natural inhibitors against SARS-CoV-2 3CLpro","volume":"11","author":"Liao","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"100195","DOI":"10.1016\/j.rechem.2021.100195","article-title":"Potential SARS-CoV-2 3CLpro Inhibitors from Chromene, Flavonoid and Hydroxamic Acid Compound based on FRET Assay, Docking and Pharmacophore Studies","volume":"3","author":"Hariono","year":"2021","journal-title":"Results Chem."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"4362","DOI":"10.1080\/07391102.2020.1779818","article-title":"Evaluation of green tea polyphenols as novel corona virus (SARS-CoV-2) main protease (Mpro) inhibitors\u2014An in silico docking and molecular dynamics simulation study","volume":"39","author":"Ghosh","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Rehman MF, U., Akhter, S., Batool, A.I., Selamoglu, Z., Sevindik, M., Eman, R., and Aslam, M. (2021). Effectiveness of Natural Antioxidants against SARS-CoV-2? Insights from the In-Silico World. Antibiotics, 10.","DOI":"10.3390\/antibiotics10081011"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s40203-020-00073-8","article-title":"Evaluation of certain medicinal plants compounds as new potential inhibitors of novel corona virus (COVID-19) using molecular docking analysis","volume":"9","author":"Alrasheid","year":"2021","journal-title":"Silico Pharmacol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s43094-021-00275-7","article-title":"Virtual screenings of the bioactive constituents of tea, prickly chaff, catechu, lemon, black pepper, and synthetic compounds with the main protease (Mpro) and human angiotensin-converting enzyme 2 (ACE 2) of SARS-CoV-2","volume":"7","author":"Emon","year":"2021","journal-title":"Futur. J. Pharm. Sci."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"5668","DOI":"10.1080\/07391102.2020.1790425","article-title":"Identification of bioactive molecule from Withania somnifera (Ashwagandha) as SARS-CoV-2 main protease inhibitor","volume":"39","author":"Tripathi","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"146400","DOI":"10.1016\/j.scitotenv.2021.146400","article-title":"Virtual screening of plant-derived compounds against SARS-CoV-2 viral proteins using computational tools","volume":"781","author":"Goytia","year":"2021","journal-title":"Sci. Total Environ."},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"van de Sand, L., Bormann, M., Alt, M., Schipper, L., Heilingloh, C.S., Steinmann, E., and Krawczyk, A. (2021). Glycyrrhizin Effectively Inhibits SARS-CoV-2 Replication by Inhibiting the Viral Main Protease. Viruses, 13.","DOI":"10.3390\/v13040609"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.csbj.2022.03.009","article-title":"Inhibition of the main protease of SARS-CoV-2 (Mpro) by repurposing\/designing drug-like substances and utilizing nature\u2019s toolbox of bioactive compounds","volume":"20","author":"Antonopoulou","year":"2022","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s43141-022-00339-y","article-title":"Molecular docking unveils the potential of andrographolide derivatives against COVID-19: An in silico approach","volume":"20","author":"Veerasamy","year":"2022","journal-title":"J. Genet. Eng. Biotechnol."},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Shady, N.H., Youssif, K.A., Sayed, A.M., Belbahri, L., Oszako, T., Hassan, H.M., and Abdelmohsen, U.R. (2020). Sterols and Triterpenes: Antiviral Potential Supported by In-Silico Analysis. Plants, 10.","DOI":"10.3390\/plants10010041"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40203-020-00071-w","article-title":"In silico investigation of saponins and tannins as potential inhibitors of SARS-CoV-2 main protease (Mpro)","volume":"9","author":"Falade","year":"2021","journal-title":"Silico Pharmacol."},{"key":"ref_121","first-page":"4538","article-title":"Tannic acid suppresses SARS-CoV-2 as a dual inhibitor of the viral main protease and the cellular TMPRSS2 protease","volume":"10","author":"Wang","year":"2020","journal-title":"Am. J. Cancer Res."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1002\/ptr.7041","article-title":"Plant-derived chemicals as potential inhibitors of SARS-CoV-2 main protease (6LU7), a virtual screening study","volume":"35","author":"Sisakht","year":"2021","journal-title":"Phytother. Res."},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Kaul, R., Paul, P., Kumar, S., B\u00fcsselberg, D., Dwivedi, V.D., and Chaari, A. (2021). Promising antiviral activities of natural flavonoids against SARS-CoV-2 targets: Systematic review. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222011069"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1039\/C8FO01997E","article-title":"The effects of polyphenols and other bioactives on human health","volume":"10","author":"Fraga","year":"2019","journal-title":"Food Funct."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.3390\/nu2121231","article-title":"Chemistry and Biochemistry of Dietary Polyphenols","volume":"2","author":"Tsao","year":"2010","journal-title":"Nutrients"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jff.2012.08.006","article-title":"Comparison of phenolic acids and flavonoids in black garlic at different thermal processing steps","volume":"5","author":"Kim","year":"2013","journal-title":"J. Funct. Foods"},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Li, F., Song, X., Su, G., Wang, Y., Wang, Z., Jia, J., Qing, S., Huang, L., Wang, Y., and Zheng, K. (2019). Amentoflavone Inhibits HSV-1 and ACV-Resistant Strain Infection by Suppressing Viral Early Infection. Viruses, 11.","DOI":"10.3390\/v11050466"},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Bernatoniene, J., and Kopustinskiene, D.M. (2018). The Role of Catechins in Cellular Responses to Oxidative Stress. Molecules, 23.","DOI":"10.3390\/molecules23040965"},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Kaihatsu, K., Yamabe, M., and Ebara, Y. (2018). Antiviral Mechanism of Action of Epigallocatechin-3-O-gallate and Its Fatty Acid Esters. Molecules, 23.","DOI":"10.3390\/molecules23102475"},{"key":"ref_130","first-page":"1","article-title":"Phytochemical rich Himalayan Rhododendron arboreum petals inhibit SARS-CoV-2 infection in vitro","volume":"28","author":"Lingwan","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"601316","DOI":"10.3389\/fpls.2020.601316","article-title":"Docking Characterization and in vitro Inhibitory Activity of Flavan-3-ols and Dimeric Proanthocyanidins against the Main Protease Activity of SARS-CoV-2","volume":"11","author":"Zhu","year":"2020","journal-title":"Front. Plant Sci."},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Park, R., Jang, M., Park, Y.-I., Park, Y., Jung, W., Park, J., and Park, J. (2021). Epigallocatechin Gallate (EGCG), a Green Tea Polyphenol, Reduces Coronavirus Replication in a Mouse Model. Viruses, 13.","DOI":"10.3390\/v13122533"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"9607","DOI":"10.1039\/D1FO01352A","article-title":"Research progress of epigallocatechin-3-gallate (EGCG) on anti-pathogenic microbes and immune regulation activities","volume":"12","author":"Zhao","year":"2021","journal-title":"Food Funct."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"100237","DOI":"10.1016\/j.phyplu.2022.100237","article-title":"Effects of theaflavin-gallate in-silico binding with different proteins of SARS-CoV-2 and host inflammation and vasoregulations referring an experimental rat-lung injury","volume":"2","author":"Maiti","year":"2022","journal-title":"Phytomed. Plus"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/10408699891274273","article-title":"Tannins and Human Health: A Review","volume":"38","author":"Chung","year":"1998","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/ecam\/neh081","article-title":"Inhibition of SARS-CoV 3C-like Protease Activity by Theaflavin-3,3\u2032-digallate (TF3)","volume":"2","author":"Chen","year":"2005","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"13051","DOI":"10.1039\/D1RA01603B","article-title":"Identification of (2R,3R)-2-(3,4-dihydroxyphenyl)chroman-3-yl-3,4,5-trihydroxy benzoate as multiple inhibitors of SARS-CoV-2 targets; a systematic molecular modelling approach","volume":"11","author":"Selvaraj","year":"2021","journal-title":"RSC Adv."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.3389\/fphar.2020.01023","article-title":"Cinnamtannin B-1 Prevents Ovariectomy-Induced Osteoporosis via Attenuating Osteoclastogenesis and ROS Generation","volume":"11","author":"Li","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Abookleesh, F.L., Al-Anzi, B.S., and Ullah, A. (2022). Potential Antiviral Action of Alkaloids. Molecules, 27.","DOI":"10.3390\/molecules27030903"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.3390\/molecules16021253","article-title":"Chemical and Pharmacological Aspects of Capsaicin","volume":"16","year":"2011","journal-title":"Molecules"},{"key":"ref_141","first-page":"16","article-title":"Phytochemical studies on Achyranthes aspera","volume":"100","author":"Abhaykumar","year":"2018","journal-title":"World Sci. News"},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Bergman, M.E., Davis, B., and Phillips, M.A. (2019). Medically Useful Plant Terpenoids: Biosynthesis, Occurrence, and Mechanism of Action. Molecules, 24.","DOI":"10.3390\/molecules24213961"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/978-0-387-46401-5_17","article-title":"Protection from Acute and Chronic Lung Diseases By Curcumin","volume":"595","author":"Venkatesan","year":"2007","journal-title":"Mol. Targets Ther. Uses Curcumin Health Dis."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.phrs.2016.11.017","article-title":"Curcumin use in pulmonary diseases: State of the art and future perspectives","volume":"115","author":"Lelli","year":"2016","journal-title":"Pharmacol. Res."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"e06350","DOI":"10.1016\/j.heliyon.2021.e06350","article-title":"Antiviral and immunomodulatory activity of curcumin: A case for prophylactic therapy for COVID-19","volume":"7","author":"Thimmulappa","year":"2021","journal-title":"Heliyon"},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Salehi, B., Upadhyay, S., Erdogan Orhan, I., Kumar Jugran, A., LDJayaweera, S., ADias, D., and Sharifi-Rad, J. (2019). Therapeutic Potential of \u03b1- and \u03b2-Pinene: A Miracle Gift of Nature. Biomolecules, 9.","DOI":"10.3390\/biom9110738"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"106","DOI":"10.2174\/138920109787048607","article-title":"Plant Extracts: Search for New Alternatives to Treat Microbial Diseases","volume":"10","author":"Alviano","year":"2009","journal-title":"Curr. Pharm. Biotechnol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.fitote.2005.06.004","article-title":"Chemical composition and pharmacological activity of essential oil of Canarium schweinfurthii","volume":"76","author":"Koudou","year":"2005","journal-title":"Fitoterapia"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.phymed.2007.03.013","article-title":"Phytochemical analysis and in vitro evaluation of the biological activity against herpes simplex virus type 1 (HSV-1) of Cedrus libani A. Rich","volume":"15","author":"Loizzo","year":"2008","journal-title":"Phytomedicine"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"6305","DOI":"10.3390\/molecules17066305","article-title":"Biological Activities of a-Pinene and \u03b2-Pinene Enantiomers","volume":"17","author":"Lopes","year":"2012","journal-title":"Molecules"},{"key":"ref_151","first-page":"3092","article-title":"Andrographolide as a potential inhibitor of SARS-CoV-2 main protease: An in silico approach","volume":"39","author":"Enmozhi","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_152","first-page":"876","article-title":"In Silico Molecular Docking Studies of Medicinal Arabic Plant-Based Bioactive Compounds as a Promising Drug Candidate against COVID-19","volume":"5","author":"Alsaffar","year":"2020","journal-title":"Int. J. Innov. Sci. Res. Technol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/np50115a001","article-title":"Isolation and Structural Elucidation of Pentacyclic Triterpenoids from Maprounea africana","volume":"58","author":"Chaudhuri","year":"1995","journal-title":"J. Nat. Prod."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ymben.2011.02.003","article-title":"Metabolic engineering tanshinone biosynthetic pathway in Salvia miltiorrhiza hairy root cultures","volume":"13","author":"Kai","year":"2011","journal-title":"Metab. Eng."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.plantsci.2019.03.007","article-title":"Tanshinone production could be increased by the expression of SmWRKY2 in Salvia miltiorrhiza hairy roots","volume":"284","author":"Deng","year":"2019","journal-title":"Plant Sci."},{"key":"ref_156","first-page":"475","article-title":"Overexpression of SmSCR1 Promotes Tanshinone Accumulation and Hairy Root Growth in Salvia miltiorrhiza","volume":"13","author":"Zhou","year":"2022","journal-title":"Front. Plant Sci."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"113177","DOI":"10.1016\/j.phytochem.2022.113177","article-title":"MAPKK2\/4\/5\/7-MAPK3-JAZs modulate phenolic acid biosynthesis in Salvia miltiorrhiza","volume":"199","author":"Xie","year":"2022","journal-title":"Phytochemistry"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00253-011-3449-2","article-title":"Metabolic engineering of flavonoids in plants and microorganisms","volume":"91","author":"Wang","year":"2011","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1093\/mp\/sst058","article-title":"Heteromeric and Homomeric Geranyl Diphosphate Synthases from Catharanthus roseus and Their Role in Monoterpene Indole Alkaloid Biosynthesis","volume":"6","author":"Rai","year":"2013","journal-title":"Mol. Plant"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"e14846","DOI":"10.1111\/ijcp.14846","article-title":"New chalcone derivatives as effective against SARS-CoV-2 agent","volume":"75","author":"Duran","year":"2021","journal-title":"Int. J. Clin. Pract."}],"container-title":["Plants"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2223-7747\/11\/14\/1862\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:52:16Z","timestamp":1760140336000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2223-7747\/11\/14\/1862"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,17]]},"references-count":160,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2022,7]]}},"alternative-id":["plants11141862"],"URL":"https:\/\/doi.org\/10.3390\/plants11141862","relation":{},"ISSN":["2223-7747"],"issn-type":[{"value":"2223-7747","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,17]]}}}